Literature DB >> 16509480

Transarterial embolization of vein of Galen malformations: the use of magnetic resonance imaging noninvasive optimal vessel analysis to quantify shunt reduction. Report of two cases.

David J Langer1, Joon K Song, Yasunari Niimi, Markus Chwajol, Daniel R Lefton, Jonathan L Brisman, Walter Molofsky, Mark J Kupersmith, Alejandro Berenstein.   

Abstract

In patients with vein of Galen malformations, high-flow shunting decreases cerebral perfusion. By reducing or eliminating these shunts, transarterial embolization can improve cerebral perfusion and clinical outcomes. Quantifying pre- and postembolization shunt blood flow may help determine the optimal timing and efficacy of embolization and may provide prognostic information. The authors used magnetic resonance imaging noninvasive optimal vessel analysis as a novel modality to measure volumetric blood flow through vein of Galen malformation shunts in a neonate and an infant before and after transarterial embolization.

Entities:  

Mesh:

Year:  2006        PMID: 16509480     DOI: 10.3171/ped.2006.104.1.41

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

1.  Quantitative Magnetic Resonance Venography is Correlated With Intravenous Pressures Before and After Venous Sinus Stenting: Implications for Treatment and Monitoring.

Authors:  Darian R Esfahani; Matthew Stevenson; Heather E Moss; Sepideh Amin-Hanjani; Victor Aletich; Sachin Jain; Fady T Charbel; Ali Alaraj
Journal:  Neurosurgery       Date:  2015-08       Impact factor: 4.654

2.  Diagnosis and treatment of vein of Galen aneurysmal malformations.

Authors:  Gregory G Heuer; Brandon Gabel; Lauren A Beslow; Michael F Stiefel; Erin S Schwartz; Phillip B Storm; Rebecca N Ichord; Robert W Hurst
Journal:  Childs Nerv Syst       Date:  2010-01-05       Impact factor: 1.475

3.  Arteriovenous shunt visualization in arteriovenous malformations with arterial spin-labeling MR imaging.

Authors:  R L Wolf; J Wang; J A Detre; E L Zager; R W Hurst
Journal:  AJNR Am J Neuroradiol       Date:  2008-04       Impact factor: 3.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.